The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Efavirenz remains a clinically effective and relevant antiretroviral drug for people living with HIV – but adverse side effects need to be screened for and monitored in children.
The number of people living with HIV experiencing more than one non-communicable disease (NCD) increased as they got older, with metabolic diseases being the biggest contributor.
Cost should not be a barrier for the full implementation of cryptococcal meningitis screening programmes for people living with HIV as per World Health Organization recommendations.
Gamification can be a powerful tool to amplify the impact of sexual health education among adolescents in schools in low-resource contexts.
Despite moderate HIV testing rates among men who have sex with men using apps in Tokyo, more needs to be done to reach those not attached to the gay community.
Disappointing results from the large-scale treatment as prevention trial in South Africa last year revealed no population level change in the number of new HIV infections – but new study reveals sexual behaviour isn’t to blame.
Climate-related events, such as droughts, are an HIV risk to already vulnerable populations of women, Lesotho study shows.
Unplanned pregnancy may be ‘a common and persistent risk factor’ for poor antiretroviral treatment outcomes in South African women living with HIV.
New research reveals that, like adults, young people have better treatment outcomes with a lower pill burden.
Matthew Hodson, Executive Director of NAM aidsmap, on how PrEP should be embraced and celebrated, and new safer sex messages accepted.